[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.176.107. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Editorial
December 2004

Beginning to Understand Hereditary Spastic Paraplegia Atlastin

Arch Neurol. 2004;61(12):1842-1843. doi:10.1001/archneur.61.12.1842

Hereditary spastic paraplegias (HSP) represent a genetically diverse set of disorders that share a common phenotype of upper motor neuron–type spasticity and weakness affecting the lower extremities. Hereditary spastic paraplegias can be categorized as noncomplicated (pure) or complicated depending on whether additional neurologic signs, such as amyotrophy, ataxia, optic atrophy, or mental retardation, are present. Certain forms of complicated HSP may also manifest systemic abnormalities, including cataracts, gastroesophageal reflux, or gastrointestinal dysfunction. There are several excellent reviews of HSP, including 1 recently published in this journal, that describe the various clinical phenotypes, gene localizations, and possible pathophysiologic mechanisms underlying HSP.1,2 However, indicative of the rapid advances in this field, new genes causative of HSP continue to be recognized at an accelerated pace. The (Table) lists the known gene loci for HSP, including the BSCL2 gene recently identified as causative of SPG17.3

First Page Preview View Large
First page PDF preview
First page PDF preview
×